Compare NVAX & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVAX | LMAT |
|---|---|---|
| Founded | 1987 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.9B |
| IPO Year | 1995 | 2006 |
| Metric | NVAX | LMAT |
|---|---|---|
| Price | $6.80 | $83.79 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 6 |
| Target Price | $9.75 | ★ $101.83 |
| AVG Volume (30 Days) | ★ 3.3M | 214.7K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | N/A | ★ 27.40 |
| EPS | 2.07 | ★ 2.32 |
| Revenue | ★ $1,064,651,000.00 | $240,866,000.00 |
| Revenue This Year | $58.91 | $15.17 |
| Revenue Next Year | N/A | $9.07 |
| P/E Ratio | ★ $3.33 | $36.43 |
| Revenue Growth | ★ 20.27 | 13.07 |
| 52 Week Low | $5.01 | $71.42 |
| 52 Week High | $11.55 | $105.55 |
| Indicator | NVAX | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 47.44 | 45.65 |
| Support Level | $6.36 | $82.52 |
| Resistance Level | $6.98 | $88.28 |
| Average True Range (ATR) | 0.22 | 2.38 |
| MACD | 0.06 | 0.23 |
| Stochastic Oscillator | 64.44 | 26.30 |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.